EverSource Wealth Advisors’s Unicycive Therapeutics UNCY Stock Holding History
Bought
Maintained
Sold
Other funds holding UNCY
EverSource Wealth Advisors's UNCY Position: Q3 2026 in Review
EverSource Wealth Advisors opened a new position in Unicycive Therapeutics (UNCY) in Q3 2026: 9 shares worth $42. The stake represents ﹤0.01% of the portfolio and ranks #4463 among its holdings.
64 funds tracked by Wall St. Rank hold UNCY as of Q3 2026.
- EverSource Wealth Advisors held 9 shares of Unicycive Therapeutics worth $42 as of Q3 2026.
- Unicycive Therapeutics was a new EverSource Wealth Advisors position in Q3 2026.
- Unicycive Therapeutics made up ﹤0.01% of EverSource Wealth Advisors's portfolio in Q3 2026, its #4463 holding.
- 64 funds tracked by Wall St. Rank held Unicycive Therapeutics as of Q3 2026.
Based on EverSource Wealth Advisors's 13F filing for Q3 2026, filed 4 Nov 2026.